Glenn Dubin C4 Therapeutics, Inc. (CCCC) insider trading activity
Glenn Dubin is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 22,075 shares of CCCC, which is worth approximately $83,664. The most recent transaction as insider was on Apr 01, 2024, when has been sold 1,358 shares (Common Stock) at a price of $8.1 per share, resulting in proceeds of $10,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
22.1K
0%
3M change
16.0%
12M change
Total Value Held
$83,664
Glenn Dubin Transaction History
GD
Glenn Dubin
Director
Watertown, MA